James H. McKerrow

University of California, San Francisco

Papers

1

Total Citations

296

H-Index

1

About

James H. McKerrow is a pioneering figure in parasitology and drug discovery, whose research has fundamentally advanced our understanding of parasitic diseases and their treatment. His work centers on the role of cysteine proteases—enzymes critical to the pathogenesis of parasites like schistosomes, trypanosomes, and leishmania—and their exploitation as drug targets. McKerrow’s landmark 2009 study on vinyl sulfones as antiparasitic agents, cited over 296 times, provided a structural basis for designing inhibitors that block these virulence factors, laying the groundwork for novel therapeutics. His contributions extend to elucidating how proteases drive tissue invasion and immune evasion in parasitic infections, with his research accumulating thousands of citations across his career. Notably, McKerrow’s work has bridged basic enzymology and translational medicine, influencing the development of drugs such as K777, a cysteine protease inhibitor tested against Chagas disease. As a former director of the Center for Discovery and Innovation in Parasitic Diseases at UCSF, he has mentored generations of scientists, leaving an indelible mark on global health. For students and researchers, McKerrow exemplifies how structural biology and chemical biology can converge to combat neglected tropical diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
296
Total Citations
296
Avg Citations/Paper
🏆 Most Cited Paper
Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design
296 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago